VREOF - Vireo Health International Inc.

Other OTC - Other OTC Delayed Price. Currency in USD

Vireo Health International Inc.

MoZaic East Building
4th Floor 1330 Lagoon Avenue
Minneapolis, MN 55408
United States
612-314-8995
http://www.vireohealth.com

SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
Full Time Employees300

Key Executives

NameTitlePayExercisedYear Born
Dr. Kyle KingsleyFounder, Chairman & CEON/AN/AN/A
Ms. Amber ShimpaCFO & DirectorN/AN/AN/A
Mr. Ari HoffnungCOO & DirectorN/AN/AN/A
Mr. Eric Greenbaum J.D.Chief Science OfficerN/AN/AN/A
Mr. Sam GibbonsVP of Investor RelationsN/AN/AN/A
Amounts are as of and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

Vireo Health International Inc. operates in cannabis industry in the United States. It engages in the cultivation, production, and sale of medical cannabis products to company owned and third party dispensaries. The company sells and distributes a suite of products through dispensaries, home delivery, and wholesale channels. The company is headquartered in Minneapolis, Minnesota.

Corporate Governance

Vireo Health International Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.